Sinclair Research Announces Toxicology Laboratory Expansion
Sinclair Research, a leading provider of nonclinical contract research services, will officially open its 20,000-square-foot...
Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that...
Schrodinger Taps Google Clouds High-Performance Compute Solution to Bolster Its Drug Discovery Efforts
Schrödinger, Inc. announced it has entered into a three-year agreement with Google Cloud to substantially...
Merck working with EOS AMCM to produce next-generation 3D printed tablets
Merck, a leading science and technology company and AMCM, Starnberg, Germany, announced a cooperation agreement...
Altasciences Adds Comprehensive Contract Manufacturing and Analytical Services to its Early Phase Research Offering
Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage...
Catalent Announces Supplying Blueprint Medicines Precision Therapy AYVAKIT
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis
Swiss pharma giant Novartis and non-profit research and development organisation Drugs for Neglected Diseases initiative...
Vir Biotechnology and WuXi Biologics Announce Collaboration for Global Development of Antibodies to Treat...
Vir Biotechnology, Inc. and WuXi Biologics announced a development and manufacturing collaboration to advance and...
Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus,...
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has initiated an accelerated research...
Native Antigen Company unveils novel coronavirus antigens
UK-based The Native Antigen Company has commercially introduced novel coronavirus antigens to help fight the...